KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in ReceivablesChange in TaxesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

AbCellera Biologics (ABCL) Change in Intangibles (2020)

Historic Change in Intangibles for AbCellera Biologics (ABCL) over the last 1 years, with Q1 2020 value amounting to $5.0 million.

  • AbCellera Biologics' Change in Intangibles changed N/A to $5.0 million in Q1 2020 from the same period last year, while for Dec 2020 it was $5.0 million, marking a year-over-year change of. This contributed to the annual value of $560000.0 for FY2023, which is 7200.0% down from last year.
  • According to the latest figures from Q1 2020, AbCellera Biologics' Change in Intangibles is $5.0 million.
  • In the past 5 years, AbCellera Biologics' Change in Intangibles registered a high of $5.0 million during Q1 2020, and its lowest value of $5.0 million during Q1 2020.